-
公开(公告)号:US20190008947A1
公开(公告)日:2019-01-10
申请号:US16136503
申请日:2018-09-20
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Sunny Himansu , Eric Yi-Chun Huang , Tal Zaks , Sayda Mahgoub Elbashir
Abstract: The disclosure relates to tropical diseases such as viral mosquito borne illnesses and the treatment thereof. The invention includes ribonucleic acid vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines for treating and preventing tropical disease.
-
公开(公告)号:US11235052B2
公开(公告)日:2022-02-01
申请号:US16853973
申请日:2020-04-21
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Sunny Himansu , Eric Yi-Chun Huang , Tal Zaks , Sayda Mahgoub Elbashir
IPC: A61K39/12 , A61K39/015 , A61P11/00 , A61K39/39 , A61K39/42 , A61K9/00 , A61K9/127 , A61K9/51 , A61K48/00 , A61K39/00
Abstract: The disclosure relates to tropical diseases such as viral mosquito borne illnesses and the treatment thereof. The invention includes ribonucleic acid vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines for treating and preventing tropical disease.
-
公开(公告)号:US10702597B2
公开(公告)日:2020-07-07
申请号:US16009880
申请日:2018-06-15
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Eric Yi-Chun Huang , Kapil Bahl , Tal Zaks , Sunny Himansu , Sayda Mahgoub Elbashir
IPC: A61K39/12 , C07K14/005 , A61K9/14 , A61K9/00 , C07K16/28 , C07K16/10 , A61K47/10 , A61K47/18 , A61K47/22 , A61K47/28 , C12N7/00 , A61P31/12 , A61P31/14 , A61K9/51 , A61K39/00
Abstract: Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include one or more RNA polynucleotides having an open reading frame encoding one or more Chikungunya antigen(s), one or more Zika virus antigens, and one or more Dengue antigens. Methods for preparing and using such vaccines are also described.
-
公开(公告)号:US10238731B2
公开(公告)日:2019-03-26
申请号:US15674591
申请日:2017-08-11
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Sunny Himansu , Eric Yi-Chun Huang , Tal Zaks , Sayda Mahgoub Elbashir
IPC: A61K39/12 , A61K48/00 , A61K39/39 , A61K39/42 , A61K9/00 , A61K9/127 , A61K9/51 , A61K39/015 , A61K39/00
Abstract: The disclosure relates to tropical diseases such as viral mosquito borne illnesses and the treatment thereof. The invention includes ribonucleic acid vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines for treating and preventing tropical disease.
-
公开(公告)号:US20230346914A1
公开(公告)日:2023-11-02
申请号:US17797784
申请日:2021-02-06
Applicant: ModernaTX, Inc.
Inventor: Guillaume Stewart-Jones , Andrea Carfi , Sayda Mahgoub Elbashir , Mihir Metkar
IPC: A61K39/215 , A61K39/145 , A61K47/10 , A61P37/04
CPC classification number: A61K39/215 , A61K39/145 , A61K47/10 , A61P37/04 , A61K2039/53
Abstract: The disclosure relates to coronavirus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The RNA vaccines encode domains and subunits of coronavirus.
-
公开(公告)号:US20230020362A1
公开(公告)日:2023-01-19
申请号:US17737532
申请日:2022-05-05
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Eric Yi-Chun Huang , Kapil Bahl , Tal Zaks , Sunny Himansu , Sayda Mahgoub Elbashir
IPC: A61K39/12 , A61K9/14 , A61K9/51 , A61K47/10 , A61K47/18 , A61K47/22 , A61K47/28 , A61K48/00 , A61P31/12 , A61P31/14 , C07K14/005 , C07K14/18 , C07K16/10 , C07K16/28 , C12N7/00 , A61K9/00
Abstract: Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include one or more RNA polynucleotides having an open reading frame encoding one or more Chikungunya antigen(s), one or more Zika virus antigens, and one or more Dengue antigens. Methods for preparing and using such vaccines are also described.
-
公开(公告)号:US20180344839A1
公开(公告)日:2018-12-06
申请号:US16009880
申请日:2018-06-15
Applicant: ModernaTX, Inc.
Inventor: Giuseppe Ciaramella , Eric Yi-Chun Huang , Kapil Bahl , Tal Zaks , Sunny Himansu , Sayda Mahgoub Elbashir
Abstract: Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include one or more RNA polynucleotides having an open reading frame encoding one or more Chikungunya antigen(s), one or more Zika virus antigens, and one or more Dengue antigens. Methods for preparing and using such vaccines are also described.
-
-
-
-
-
-